Table 2.
Change in health status and symptom scores of 4 the groups of COPD patients at exacerbations compared to stable visits
| A (n = 10) | B (n = 16) | C (n = 19) | D (n = 58) | p value | |
|---|---|---|---|---|---|
|
Δ CRQ Fatigue (unit) |
-1.36 (-2.61 to -0.12)* |
-1.33 (-2.35 to -0.31)* |
-1.11 (-1.76 to -0.45)* |
-1.00 (-2.61 to -0.12)* |
0.78 |
|
Δ CRQ Dyspnoea (unit) |
-1.49 (-2.92 to -0.05)* |
-1.05 (-2.32 to 0.21)* |
-1.04 (-1.41 to -0.67)* |
-0.57 (-0.98 to -0.15)* |
0.34 |
|
Δ CRQ Emotion (unit) |
-1.22 (-1.52 to -0.91)* |
-1.07 (-2.00 to -0.14)* |
-0.62 -1.27 to 0.02)* |
-0.89 (-1.31 to -0.46)* |
0.67 |
|
Δ CRQ Mastery (unit) |
-0.99 (-2.33 to 0.36)* |
-0.97 (-2.28 to 0.34)* |
-1.10 (-1.99 to -0.21)* |
-0.75 (-1.09 to -0.41)* |
0.59 |
|
Δ CRQ total (unit) |
-1.26 (-2.21 to -0.32)* |
-1.12 (-1.99 to -0.22)* |
-0.97 (-1.49 to -0.44)* |
-0.79 (-1.04 to -0.55)* |
0.54 |
|
Δ VAS cough (mm) |
22 (3 to 42)* |
35 (21 to 48)* |
7 (3 to 42)* |
27 (18 to 36)* |
0.06 |
|
Δ VAS dyspnoea (mm) |
34 (3 to 65)* |
35 (20 to 51)* |
17 (-2 to 35) |
25 (17 to 33)* |
0.31 |
|
Δ VAS sputum production (mm) |
8 (-32 to 49) |
24 (-2 to 50) |
9 (-2 to 21) |
21 (12 to 29)* |
0.45 |
| Δ VAS sputum purulence (mm) | 28 (-13 to 68) | 18 (-5 to 42) | 31(17 to 45)* | 15 (5 to 24)* | 0.36 |
Data presented as mean (95% CI) unless stated; *p < 0.05 stable versus exacerbation.